CURT FREED, MD
Osteopathic Medicine at 16 Ave, Denver, CO
License number
Colorado 19623
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
12605 E 16Th Ave, Denver, CO 80045
Phone
(720) 848-0000
(303) 493-7000
(303) 493-7000
Personal information
See more information about CURT FREED at radaris.comName
Address
Phone
9080 E Jewell Cir, Denver, CO 80231
Aurora, CO
9080 Jewell Cir, Denver, CO 80231
2 Adams St, Denver, CO 80206
4200 9Th Ave, Denver, CO 80220
Organization information
See more information about CURT FREED at bizstanding.comCurt Freed MD
1772 Platte St, Denver, CO 80202
Industry:
Internist
Phone:
(303) 468-3480 (Phone)
Curt Richard Freed
Curt Freed
4200 E 9 Ave, Denver, CO 80220
Status:
Inactive
Industry:
Medical Doctor's Office
Owner, Principal:
Curt R. Freed Owner, Principal, inactive
Professional information
Professor Of Medicine, Pharmacology, And Neurosurgery At University Of Colorado Denver Business School
Location:
Greater Denver Area
Industry:
Higher Education
Dr. Curt R Freed, Aurora CO - MD (Doctor of Medicine)
Specialties:
Clinical Pharmacology, Internal Medicine
Address:
12700 E 19Th Ave, Aurora 80045
(303) 724-6002 (Phone)
12605 E 16Th Ave, Aurora 80045
(720) 848-0000 (Phone)
(303) 724-6002 (Phone)
12605 E 16Th Ave, Aurora 80045
(720) 848-0000 (Phone)
Languages:
English
Hospitals:
12700 E 19Th Ave, Aurora 80045
12605 E 16Th Ave, Aurora 80045
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
12605 E 16Th Ave, Aurora 80045
University of Colorado Hospital - Anschutz Inpatient Pavilion
12605 East 16Th Avenue Dr, Aurora 80045
Education:
Medical School
Harvard Medical School
Graduated: 1969
La Co Harbor UCLA Med Center
Mass Gen Hospital
Moffitt Hospital University Of Ca
Harvard Medical School
Graduated: 1969
La Co Harbor UCLA Med Center
Mass Gen Hospital
Moffitt Hospital University Of Ca
Curt R Freed, Aurora CO
Specialties:
Internist
Address:
12605 E 16Th Ave, Aurora, CO 80045
12700 E 19Th Ave, Aurora, CO 80045
12700 E 19Th Ave, Aurora, CO 80045
Dopamine Neurons From Human Embryonic Stem Cells
US Patent:
2004014, Jul 29, 2004
Filed:
Oct 30, 2003
Appl. No.:
10/699302
Inventors:
Curt Freed - Denver CO, US
Assignee:
The Regents of the University of Colorado, a body corporate
International Classification:
C12N005/08
US Classification:
435/368000
Abstract:
The present invention relates to methods and compositions for differentiating human embryonic stem cells into dopamine producing neurons. The methods and compositions of the present invention are suitable for use in the treatment of neurological disorders.
Use Of Kinase Inhibitors For Treating Neurodegenerative Diseases
US Patent:
6288089, Sep 11, 2001
Filed:
Dec 21, 1999
Appl. No.:
9/469980
Inventors:
Michael Zawada - Denver CO
Kim Heidenreich - Denver CO
Curt Freed - Denver CO
Kim Heidenreich - Denver CO
Curt Freed - Denver CO
International Classification:
A61K 3144, A61K 31505
US Classification:
514341
Abstract:
The present invention relates to methods of treating neurodegenerative diseases, including but not limited to Parkinson's disease. In particular, the present invention provides methods utilizing the administration of pyridyl imidazoles having simultaneous inhibitory activity towards p38 mitogen-activated protein (MAP) kinase and c-jun-N-terminal kinase (JNK). The present invention also provides methods for preventing apoptosis of dopamine neurons using pyridyl imidazoles. The present invention also provides methods for the treatment of neurodegenerative diseases, including but not limited to Parkinson's disease.
Method Of Treating Huntington's Disease Using Hnt Neurons
US Patent:
6254865, Jul 3, 2001
Filed:
Jun 17, 1998
Appl. No.:
9/099121
Inventors:
Curt R. Freed - Denver CO
Farida G. Kaddis - Lakewood CO
Farida G. Kaddis - Lakewood CO
Assignee:
University Technology Corporation - Boulder CO
International Classification:
A61K 3500
US Classification:
424 937
Abstract:
The present invention relates to methods and compositions for transplantation of neurons. The methods and compositions of the present invention provide a renewable supply of safe and effective therapeutic transplantable tissue. In particular, the present invention provides methods and compositions for the transplantation of terminally differentiated neurons derived from cell lines for the treatment of Huntington's disease and other neurological disorders.
Immortalized Human Fetal Neuronal Cell Line
US Patent:
6232119, May 15, 2001
Filed:
Jun 12, 1998
Appl. No.:
9/097212
Inventors:
Kedar N. Prasad - Denver CO
Curt R. Freed - Denver CO
Curt R. Freed - Denver CO
Assignee:
University Technology Corporation - Boulder CO
International Classification:
C12N 508, C12N 500, C12N 1563
US Classification:
435368
Abstract:
An immortalized line of human fetal brain cells capable of synthesizing dopamine has been developed. No tumor formation or rejection at 30 days post-transplantation has been detected. The cells are useful for transplantation therapy of a neurological deficit characterized by dopamine deficiency in the local region of the brain.